WallStreetZenWallStreetZen

NASDAQ: STRO
Sutro Biopharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

STRO past revenue growth

How has STRO's revenue growth performed historically?
Company
126.84%
Industry
149.51%
Market
17.15%
STRO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
STRO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
STRO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

STRO earnings and revenue history

Current Revenue
$153.7M
Current Earnings
-$106.8M
Current Profit Margin
-69.5%

STRO Return on Equity

Current Company
-70.9%
Current Industry
-63.5%
Current Market
188%
STRO's Return on Equity (-70.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when STRO announces earnings.

STRO Return on Assets

Current Company
-24.8%
Current Industry
2.9%
STRO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

STRO Return on Capital Employed

Current Company
-20.54%
Current Industry
19.5%
STRO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

STRO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
STRO$153.73M-$66.98M-$106.79M+31.96%N/A
INO$832.01k-$130.39M-$135.12M-51.33%N/A
ALDX$0.00-$35.21M-$37.54MN/AN/A
NKTR$90.12M-$243.11M-$276.06M-40.35%N/A
FHTX$34.16M-$85.54M-$98.43M+428.05%N/A
View Top Biotech Stocks

STRO earnings dates

Next earnings date
May 13, 2024

Sutro Biopharma Earnings & Revenue FAQ

What were STRO's earnings last quarter?

On Invalid Date, Sutro Biopharma (NASDAQ: STRO) reported Q4 2023 earnings per share (EPS) of $0.52, up 185.25% year over year. Total Sutro Biopharma earnings for the quarter were $31.07 million. In the same quarter last year, Sutro Biopharma's earnings per share (EPS) was -$0.61.

If you're new to stock investing, here's how to buy Sutro Biopharma stock.

What was STRO's earnings growth in the past year?

As of Q2 2024, Sutro Biopharma's earnings has grown year over year. Sutro Biopharma's earnings in the past year totalled -$106.79 million.

What is STRO's earnings date?

Sutro Biopharma's earnings date is Invalid Date. Add STRO to your watchlist to be reminded of STRO's next earnings announcement.

What was STRO's revenue last quarter?

On Invalid Date, Sutro Biopharma (NASDAQ: STRO) reported Q4 2023 revenue of $113.72 million up 1,217.44% year over year. In the same quarter last year, Sutro Biopharma's revenue was $8.63 million.

What was STRO's revenue growth in the past year?

As of Q2 2024, Sutro Biopharma's revenue has grown 126.84% year over year. This is 22.68 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Sutro Biopharma's revenue in the past year totalled $153.73 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.